METHODS: This subanalysis stems from a multicenter retrospective cohort study across 16 stroke centers from January 2015 to December 2020. Patients with anterior circulation TLs who underwent EVT were included. Successful reperfusion was defined as a modified Thrombolysis in Cerebral Infarction scale ≥2B by the local team at each participating center. Mediation analysis was conducted to examine the potential causal pathway in which the relationship between acute CAS and functional outcome (90-day modified Rankin Scale) is mediated by successful reperfusion.
RESULTS: A total of 570 patients were included, with a median age (interquartile range) of 68 (59-76), among whom 180 (31.6%) were female. Among these patients, 354 (62.1%) underwent acute CAS and 244 (47.4%) had a favorable functional outcome. The remaining 216 (37.9%) patients were in the non-CAS group. The CAS group had significantly higher rates of successful reperfusion (91.2% vs 85.1%; p = 0.025) and favorable functional outcomes (52% vs 29%; p = 0.003) compared with the non-CAS group. Successful reperfusion was a strong predictor of functional outcome (adjusted common odds ratio [acOR] 4.88; 95% CI 2.91-8.17; p < 0.001). Successful reperfusion partially mediated the relationship between acute CAS and functional outcome, as acute CAS remained significantly associated with functional outcome after adjustment for successful reperfusion (acOR 1.89; 95% CI 1.27-2.83; p = 0.002). Successful reperfusion explained 25% (95% CI 3%-67%) of the relationship between acute CAS and functional outcome.
CONCLUSIONS: In patients with TL undergoing EVT, successful reperfusion predicted favorable functional outcomes when CAS was performed compared with non-CAS. A considerable proportion (25%) of the treatment effect of acute CAS on functional outcome was found to be mediated by improvement of successful reperfusion rates.
方法:本子分析来自2015年1月至2020年12月在16个卒中中心进行的多中心回顾性队列研究。包括接受EVT的前循环TLs患者。成功的再灌注定义为每个参与中心的当地团队改良的脑梗死溶栓评分≥2B。进行了中介分析,以检查成功再灌注介导急性CAS与功能结局(90天改良的Rankin量表)之间关系的潜在因果途径。
结果:共纳入570例患者,年龄中位数(四分位数范围)为68(59-76),其中180人(31.6%)为女性。在这些患者中,354例(62.1%)接受急性CAS,244例(47.4%)具有良好的功能结局。其余216例(37.9%)患者属于非CAS组。与非CAS组相比,CAS组的再灌注成功率(91.2%vs85.1%;p=0.025)和良好的功能结局(52%vs29%;p=0.003)明显更高。成功的再灌注是功能预后的强预测因子(校正后的普通比值比[acOR]4.88;95%CI2.91-8.17;p<0.001)。成功的再灌注部分介导了急性CAS与功能结局之间的关系,因为在校正成功再灌注后,急性CAS仍然与功能结局显著相关(acOR1.89;95%CI1.27-2.83;p=0.002).成功的再灌注解释了急性CAS与功能结局之间关系的25%(95%CI3%-67%)。
结论:在接受EVT的TL患者中,与非CAS相比,成功的再灌注预测了CAS时良好的功能结局.发现急性CAS对功能结果的治疗作用中有相当大的比例(25%)是由成功再灌注率的提高介导的。